Indivior Pharmaceuticals (INDV) Tax Rate (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded quarterly Tax Rate of 22.61% in Q1 2026, up 187.2% quarter-over-quarter from 25.93% in Q4 2025, and up 396.0% on a YoY basis from 4.56% in Q1 2025.
Indivior Pharmaceuticals (INDV) Tax Rate (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Tax Rate history runs 3 years deep, the most recent figure standing at 22.61% for Q1 2026.
- In Q1 2026, Tax Rate rose 396.0% year-over-year to 22.61%; the TTM figure through Mar 2026 stood at 14.92% (down 20175.0% YoY), while the FY2025 annual figure was 12.13%, down 5287.0% from the prior year.
- Tax Rate was 22.61% for Q1 2026 at Indivior Pharmaceuticals, up from 25.93% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 70.97% in Q2 2025 to a low of 25.93% in Q4 2025.
- Historically, Tax Rate has averaged 19.81% across 3 years, with a median of 19.01% in 2024.
- Biggest YoY gain for Tax Rate was 5196 bps in 2025; the steepest drop was 7066 bps in 2025.
- A 3-year view of Tax Rate shows it stood at 44.74% in 2024, then tumbled by 158 bps to 25.93% in 2025, then jumped by 187 bps to 22.61% in 2026.
- The last three Tax Rate figures came in at 22.61% (Q1 2026), 25.93% (Q4 2025), and 13.51% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 15.33% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.71% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 13.63% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -20.44% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 19.81% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 34.48% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -7.43% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 24.29% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 9.29% |
| 10 | Indivior Pharmaceuticals | - | - | 277.00 Mn | 22.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.61% |
| Mar 31, 2026 | 22.61% |
| Dec 31, 2025 | -25.93% |
| Dec 31, 2025 | -25.93% |
| Sep 30, 2025 | -13.51% |
| Sep 30, 2025 | -13.51% |
| Jun 30, 2025 | 70.97% |
| Jun 30, 2025 | 70.97% |
| Mar 31, 2025 | 18.64% |
| Mar 31, 2025 | 18.64% |
| Dec 31, 2024 | 44.74% |
| Dec 31, 2024 | 44.74% |
| Sep 30, 2024 | 26.67% |
| Sep 30, 2024 | 26.67% |
| Jun 30, 2024 | 19.01% |
| Jun 30, 2024 | 19.01% |
| Mar 31, 2024 | 15.07% |
| Mar 31, 2024 | 15.07% |